EchoLaser

EchoLaser

EchoLaser: the first and unique integrated system dedicated to diagnostic Ultrasound and Laser thermal ablation therapy

Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries.
  • Overview
  • Features Insight
  • Download

EchoLaser: The New Approach to Minimally Invasive Technique

EchoLaser is the first and unique integrated system dedicated to diagnostic Ultrasound and Laser thermal ablation therapy. Percutaneous laser ablation (PLA) is a mini invasive procedure that uses the laser light for a few minutes to heat a solid tumour until an irreversible in situ damage occurs.

PLA can be performed under ultrasound guidance for real time monitoring of the correct positioning of the laser light applicators and the effective extension of damage generated on the cancer lesion.

A Wide Range of Effective Applications

EchoLaser is suited for echo-guided percutaneous laser ablation of biological tissue such as benign and malignant lesions in various organs. The main applications currently involve the reduction of benign thyroid nodules and destruction of primary/secondary malignant liver lesions.

Further applications are being researched to assess their effectiveness, safety and long-range clinical results on other organs such as metastatic lymph nodes in the neck, pancreas, breast and prostate tumors.

How the laser works

The laser light is conveyed from the source to the tissue through extremely flexible, small-gauge (300 μm in diameter) flat-tipped quartz optical fibres, introduced percutaneously by thin needles (21 Gauge). Laser emission through a flat-tipped fibre produces a lesion (coagulation area) with an ellipsoidal shape, one third of which is positioned behind the tip of the fibre, and two-thirds in front.

Mini-Invasive Technique for the Highest Effectiveness of Treatment

EchoLaser is fully developed for applications of PLA for solid tumours in order to achieve high effectiveness of treatment. EchoLaser fulfils all basic requirements of mini-invasive techniques:

  • mini-invasiveness
    • control of the shape of the coagulative necrosis:
    • adaptability of the necrosis shape and volume to the specific disease
    • confinement in respect of the viable parts and critical areas of the organs
    • repeatability and predictability of the thermal lesion
  • safety - EMC compatibility and electrical safety
  • speed - rapid performance of the treatment
  • real-time monitoring of the treatment

EchoLaser is a product of Elesta joint venture Esaote - El.En.
EchoLaser is not yet available for sales in the USA.
Windows® is a registered trademark of Microsoft Corporation.

Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.

The first and unique integrated system dedicated to Diagnostic Ultrasound and Laser Thermal Ablation Therapy

EchoLaser: integrated system to satisfy clinical needs

EchoLaser, MyLab™ClassC, MyLab™Twice, MyLab™70 are complete, dedicated, integrated interventional ultrasound-laser systems for Diagnostics, Interventional and Minimally Invasive Thermal Ablation procedures. They are provided with disposable optical fibre kits specially designed to approach various organs together with specific guiding systems. The system is highly appreciated for its diagnostic performance and interventional options, combined with the laser features: it represents the advanced concept and solution to satisfy all clinical needs with integrated systems dedicated to advanced interventional and therapy applications.

Diagnosis, Therapy and Treatment All in One Solution

EchoLaser system is composed of:

  • Ultrasound system based on Esaote MyLab™Twice/MyLab™ClassC/MyLab™70 platform with all features, transducers, advanced tools (Fusion imaging included) and options of the standard version plus Laser Guidance Tool, the dedicated software to guide the operator in needle insertion, positioning on lesion and prediction of thermal lesion operations

Laser system based on El.En. EchoLaser X4 device with following main specification:

  • Laser Type: Solid state
  • Number of Sources: 4 independent in activation and emission
  • Wavelength: 1064nm
  • Emission Mode: CW
  • Maximum Power (CW): 7 W for fibre
  • Output Mode: Multimode
  • Divergence (at the output of application’s system): 240 mrad
  • Aiming Beam: Diode laser 3 mW @ 635 nm
  • Stability of the Output Power: ±20%
  • Nominal Ocular Hazard Distance (NOHD): 4 m
  • Control Panel: LCD Colour Touch Screen
    • SMA 905 optical connector
    • 1.5m length
    • 300 μm “core” diameter

EchoLaser: integrated solution for Diagnostic Ultrasound and Laser Thermal Ablation Therapy

Technology and features are system/configuration dependent. Specifications subject to change without notice.
Information might refer to products or modalities not yet approved in all countries.
For further details, please contact your Esaote sales representative.

Connectivity

EchoLaser - Connectivity

From the very beginning of Information Technology diffusion in the medical environment, Esaote has been recognized as a world leader in managing/sharing clinical data, providing a solid contribution to the revolution that is bringing the medical world to an unexpected level of efficiency.

For latest updates and/or any further information not included in this section, please contact connectivity(at)esaote.com

Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.

Peripherals

Esaote suggests a complete range of dedicated Printers and DVRs which can be connected to your ultrasound scanner to allow the best image quality printing and cover any specific need in diagnostic archiving. Choose your own commercial printer and get the best image quality you wonder.

The Ultrasound Peripherals connectible to the echograph are system/configuration dependent.

To receive more info about the specific characteristics and the compatibility with the present ultrasound system, please send your requests to your Esaote sales representative.

Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries.
For further details, please contact your Esaote sales representative.

Certifications

The MyLab™Twice, MyLab™ClassC, MyLab™70 systems, manufactured by Esaote, comply with the Medical Device Directive (MDD) 93\42\EEC. In accordance with this directive, Esaote has classified them as Class IIa devices.

The MyLab™Twice, MyLab™ClassC, MyLab™70 ultrasound imaging systems have been cleared by the Food and Drug Administration (FDA) via 510(k).



The EchoLaser X4 laser unit, manufactured by El.En., complies with the Medical Device Directive (MDD) 93\42\EEC. In accordance with this directive, El.En has classified it as Class IIb devices.

Technology and features are system/configuration dependent. Specifications subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.

Clinical Images

Benign thyroid nodule (id. 1) with peripheral vascularity (vol. 5ml) before laser treatment
Benign thyroid nodule (id. 1) - 1 month after treatment
Benign thyroid nodule (id. 2) with vascularization (vol. 21.5ml)
Benign thyroid nodule (id. 2) - 6 months after treatment - 73% volume reduction
HCC adjacent to right portal vein before laser treatment
HCC adjacent to right portal vein immediately after laser treatment - vessel is unchanged
Schedule of laser treatment of a thyroid nodule with laser Echo-guide dedicated option

Probes

Echolaser-CA431

Echolaser-CA431_A

Echolaser-CA541

Echolaser-CA541_A

Echolaser-LA332

Echolaser-LA332_A

IOE323

Intraoperative, Vascular, Small Parts Linear Array

CA621

Abdominal, Ob/Gyn, Vascular  Convex Array

CA631

Abdominal, Ob/Gyn, Vascular, Contrast Agents Procedures Variable-Band Convex Array

CA431

Abdominal, Ob/Gyn, Vascular, Contrast Agents Procedures  Variable-Band Convex Array

CA430

Abdominal, Ob/Gyn, Vascular, Contrast Agents Procedures  Variable-Band Convex Array

CA421

Abdominal, Ob/Gyn, Vascular  Convex Array

CA123

Neonatal, Abdominal, Vascular  Micro-convex Array

BC431

Abdominal, Ob/Gyn, Contrast Agents Procedures  Variable-Band Bi-scan Volumetric Convex Array

LA532

Vascular, Small Parts, Contrast Agents Procedures Variable-Band Linear Array

LA523

Vascular, Small Parts, Contrast Agents Procedures, Rheumatology, Anaesthesiology Variable-Band Linear Array

LA522

Vascular, Pediatric, Small Parts, Contrast Agents Procedures Variable-Band Linear Array

LA435

Vascular, Small Parts, Pediatric, Rheumatology, Anaesthesiology Linear Array

PA230

Cardiac, Transcranial, Abdominal, Vascular, Contrast Agents Procedures  Variable-Band Phased Array

PA122

Cardiac Pediatric, Vascular, Transcranial  Phased Array

PA121

Cardiac, Pediatric, Abdominal, Vascular Phased Array

EC123

Transvaginal, Transrectal, Contrast Agents Procedures Variable-Band Micro-Convex Array

TRT33 Bi-plane

Transrectal, Transvaginal Micro-Convex Array & Linear Array

TEE022 Multiplane

Cardiac Phased Array

Pencil CW 5

Vascular Pencil Array - 5 MHz

Pencil CW 2

Cardiac, Pediatric Pencil Array - 2 MHz
Echolaser-CA431
Echolaser-CA431_A
Echolaser-CA541
Echolaser-CA541_A
Echolaser-LA332
Echolaser-LA332_A
IOE323
CA621
CA631
CA431
CA430
CA421
CA123
BC431
LA532
LA523
LA522
LA435
PA230
PA122
PA121
EC123
TRT33 Bi-plane
TEE022 Multiplane
Pencil CW 5
Pencil CW 2
This page uses cookies. Visiting this web site, you approve the use of cookies. For more information about the use of cookies in this web site, please click on “More information”. I agree More information